alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
<TABLE>
<CAPTION>

   Schedule of Year-To-Date Principal and Interest Distributions
                           to
                  Certificateholders

                                                                             Ending
Class                 Interest             Principal        Losses           Balance
<S>                    <C>                  <C>              <C>             <C>
A-1A                  8,213,673.81        6,930,377.32         0.00           234,679,622.68
A-1B                 32,492,409.48                0.00         0.00           890,203,000.00
A-2                   2,598,895.26                0.00         0.00            69,769,000.00
A-3                   3,102,637.84                0.00         0.00            81,398,000.00
A-4                     749,065.53                0.00         0.00            19,380,000.00
B-1                   2,247,235.23                0.00         0.00            58,141,000.00
B-2                     898,917.28                0.00         0.00            23,257,000.00
B-3                   1,182,210.48                0.00         0.00            38,761,000.00
B-4                     945,744.00                0.00         0.00            31,008,000.00
B-5                     473,677.74                0.00         0.00            15,505,000.00
B-6                     592,059.00                0.00         0.00            19,380,000.00
B-7                     473,647.20                0.00         0.00            15,504,000.00
B-8                     473,677.74                0.00         0.00            15,505,000.00
C                       944,601.65                0.00         0.00            31,008,606.00
D-1                           0.00                0.00         0.00                     0.00
D-2                           0.00                0.00         0.00                     0.00
R-I                           0.00                0.00         0.00                     0.00
R-II                          0.00                0.00         0.00                     0.00
R-III                         0.00                0.00         0.00                     0.00
S                     4,425,471.82                0.00         0.00                     0.00


</TABLE>
EXHIBIT 32.1

Certification of CEO Pursuant to

18 U.S.C. Section 1350,

as Adopted Pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned, the Chief Executive
Officer of Angiotech Pharmaceuticals, Inc. (the Company), hereby certifies that to his knowledge on the date hereof:



|(a) | The Quarterly Report on Form 10-Q of the Company for the quarter ended June 30, 2011, filed on the date hereof with the Securities and Exchange Commission (the
Report) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



|(b) | Information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
|--- | ------------------------------------------------------------------------------------------------------------------------------------------------



|                     |  |                                                
|-------------------- |  | -----------------------------------------------
|Date: August 9, 2011 |  | /s/    William L. Hunter                       
|                     |  | William L. Hunter, M.D. Chief Executive Officer
Exhibit 32

                Certifications Pursuant to 18 U.S.C. Section 1350

         The  undersigned,  who are the chief  executive  officer  and the chief
financial  officer of Cornerstone  Bancorp,  each hereby  certifies that, to the
best of his/her  knowledge,  the  accompanying  Form 10-KSB of the issuer  fully
complies  with the  requirements  of  Section  13(a)or  15(d) of the  Securities
Exchange  Act of 1934,  and that  information  contained  in the  report  fairly
presents,  in all material  respects,  the  financial  condition  and results of
operations of the issuer.

March 25, 2004

                             s/J. Rodger Anthony
                             ------------------------------------------------
                                J. Rodger Anthony
                                Chief Executive Officer


                             s/Jennifer M. Champagne
                             ------------------------------------------------
                               Jennifer M. Champagne
                               Chief Financial Officer
Exhibit
32.2





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that, to his
knowledge, the annual report on Form 10-K (the “Report”) of Intermost
Corporation, a Wyoming corporation (the “Company”), for the period ended June
30, 2008:





1.
            Fully
      complies with the requirements of Section 13(a) or 15(d), as applicable,
      of the Securities Exchange Act of 1934, as amended;
  and




2.
            The
      information contained in the Report fairly presents, in all material
      respects, the financial condition and results of operations of the
      Company.





This certification is being provided
pursuant to 18 U.S.C. 1350 and is not to be deemed a part of this Report, nor is
it to be deemed to be “filed” for any purpose whatsoever.





Date: October
9, 2009





By:
              /s/ Thomas LeeThomas
      Lee,Chief
      Financial Officer





A signed
original of this written statement required by Section 906 of the Sarbanes-Oxley
Act of 2002 has been provided to the Company, and will be retained by the
Company, and furnished to the Securities and Exchange Commission upon
request.
EXHIBIT 99.1

                                  CERTIFICATION

This certification is provided pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002 and accompanies the quarterly  report on Form 10-Q (the "Form 10-Q") for
the quarter ended June 30, 2003 of American Insured Mortgage  Investors - Series
85, L.P. (the "Issuer").

I,  Barry S.  Blattman,  Chairman  of the Board,  Chief  Executive  Officer  and
President, certify that to the best of my knowledge:

     (i)  the Form 10-Q fully complies with the requirements of section 13(a) or
          section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m(a)
          or 78o(d)); and

     (ii) the information  contained in the Form 10-Q fairly represents,  in all
          material respects,  the financial  condition and results of operations
          of the Issuer.


                                           AMERICAN INSURED MORTGAGE
                                           INVESTORS - SERIES 85, L.P.
                                           (Registrant)

                                           By: CRIIMI, Inc.
                                               General Partner



August 13, 2003                            /s/ Barry S. Blattman
---------------                            -------------------------------------
Date                                       Barry S. Blattman
                                           Chairman of the Board,
                                           Chief Executive Officer and President

A signed  original of this  written  statement  required by Section 906 has been
provided to the General  Partner and will be retained by the General Partner and
furnished to the Securities and Exchange Commission or its staff upon request.
II 

112TH CONGRESS 

2D SESSION S. 3225 

To require the United States Trade Representative to provide documents 

relating to trade negotiations to Members of Congress and their staff 

upon request, and for other purposes. 

IN THE SENATE OF THE UNITED STATES 

MAY 23, 2012 

Mr. WYDEN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To require the United States Trade Representative to provide 

documents relating to trade negotiations to Members of 

Congress and their staff upon request, and for other 

purposes. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Congressional Over5 sight Over Trade Negotiations Act’’. 


tjames on DSK6SPTVN1PROD with BILLS
2 

•S 3225 IS

1 SEC. 2. ACCESS OF MEMBERS OF CONGRESS AND THEIR 

2 STAFF TO DOCUMENTS RELATING TO TRADE 

3 NEGOTIATIONS. 

4 (a) PURPOSES.—The purposes of this section are— 

5 (1) to ensure the adequate consultation of the 

6 United States Trade Representative with Members 

7 of Congress; 

8 (2) to provide Members of Congress with appro9 priate opportunities— 

10 (A) to advise the Trade Representative 

11 with respect to the formulation of trade policy; 

12 and 

13 (B) to propose specific negotiating objec14 tives for trade negotiations; and 

15 (3) to provide Members of Congress with the 

16 information necessary to assess compliance with and 

17 enforcement of commitments made by countries that 

18 are parties to trade agreements with the United 

19 States. 

20 (b) ACCESS TO CERTAIN DOCUMENTS.—Notwith21 standing section 2107 of the Bipartisan Trade Promotion 

22 Authority Act of 2002 (19 U.S.C. 3807) or any other pro23 vision of law, the United States Trade Representative shall 

24 provide access to documents, including classified mate25 rials, relating to negotiations for a trade agreement to 

26 which the United States may be a party and policies adVerDate Mar 15 2010 00:48 May 24, 2012 Jkt 019200 PO 00000 Frm 00002 Fmt 6652 Sfmt 6201 E:\BILLS\S3225.IS S3225

tjames on DSK6SPTVN1PROD with BILLS
3 

•S 3225 IS

1 vanced by the Trade Representative in such negotiations 

2 to— 

3 (1) any Member of Congress that requests such 

4 documents; and 

5 (2) staff of such a Member with proper security 

6 clearances. 

Æ 


tjames on DSK6SPTVN1PROD with BILLS
Electronically Filed

Intermediate Court of Appeals

CAAP-19-0000329

05-JUL-2019

10:59 AM
Exhibit 32.1



Certification of Chief Executive Officer Pursuant to

18 U.S.C. Section 1350, as Adopted Pursuant to

Section 906 of the
Sarbanes-Oxley Act of 2002



I, Vincent C. Smith, certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that the Annual Report of Quest Software, Inc. on Form 10-K for the year ended December 31, 2004, fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained in such Report fairly presents, in all material respects, the financial condition and results of operations of Quest Software, Inc.



|                     |  |        |  |                        
|-------------------- |  | ------ |  | -----------------------
|Date: March 16, 2005 |  | By:    |  | /s/    VINCENT C.
SMITH
|                     |  | Name:  |  | Vincent C. Smith       
|                     |  | Title: |  | Chief Executive Officer
# Official Journal C 389/24 S

| | ISSN 1977-091X |
| --- | --- |
| Official Journal
  of the European Union | C 389 |
| | |
| English edition | Information and Notices | Volume 6424 September 2021 |

ISSN 1977-091X

Official Journal

of the European Union

C 389

English edition

Information and Notices

Volume 6424 September 2021

---

| Contents | page |
| --- | --- |
| | II   Information |
| | INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES |
| | European Commission |
| 2021/C 389/01 | Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union — Cases where the Commission raises no objections (
  1
  ) | 1 |

Contents

page

II   Information

INFORMATION FROM EUROPEAN UNION INSTITUTIONS, BODIES, OFFICES AND AGENCIES

European Commission

2021/C 389/01

Authorisation for State aid pursuant to Articles 107 and 108 of the Treaty on the Functioning of the European Union — Cases where the Commission raises no objections (
  1
  )

1

1

---

| | |
| --- | --- |
| | (1)   Text with EEA relevance. |

---

(1)   Text with EEA relevance.

1

| EN | |
| --- | --- |

EN
```

[Congressional Bills 112th Congress]
[From the U.S. Government Publishing Office]
[S. 3162 Introduced in Senate (IS)]

112th CONGRESS
  2d Session
                                S. 3162

           To suspend temporarily the duty on Flubendiamide.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                              May 10, 2012

  Mrs. Hagan introduced the following bill; which was read twice and 
                  referred to the Committee on Finance

_______________________________________________________________________

                                 A BILL

 
           To suspend temporarily the duty on Flubendiamide.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. FLUBENDIAMIDE.

    (a) In General.--Subchapter II of chapter 99 of the Harmonized 
Tariff Schedule of the United States is amended by inserting in 
numerical sequence the following new heading:

``     9902.01.00      N1-[1,1-Dimethyl-2- Free         No change        No change        On or before 12/  ''.
                        mesylethyl-3-iodo-                                                 31/2015.......
                        N2-{2-methyl-4-
                        [1,2,2,2-
                        terafluoro-1-
                        (trifluoromethyl)
                        ethyl]phenyl}phth
                        alamide
                        (Flubendiamide)
                        (CAS No. 272451-
                        65-7) (provided
                        for in subheading
                        2930.90.10)......

    (b) Effective Date.--The amendment made by subsection (a) applies 
with respect to goods entered, or withdrawn from warehouse for 
consumption, on or after the 15th day after the date of the enactment 
of this Act.
                                 <all>
```
# C_2005007EN.01000301.xml

| 11.1.2005 | EN | Official Journal of the European Union | C 7/3 |
| --- | --- | --- | --- |

11.1.2005

EN

Official Journal of the European Union

C 7/3

---

Non-opposition to a notified concentration

(Case COMP/M.3544 — Bayer Healthcare/Roche (OTC Business))

(2005/C 7/03)

(Text with EEA relevance)

On 19 November 2004, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(2) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32004M3544. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex). |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32004M3544. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex).

---
Reginald Parks

– Marketing Manager, Florida Citrus Sports

– 1 Citrus Bowl Place, Orlando, FL 32805

To whom it may concern,
We at Florida Citrus Sports would like to have clearance to fly the DJI Phantom 2 as well as the Aspire 1 during the months of December 2015 and January 2016 solely for mar keting pur poses. With thi s petition we vow to not fly the said aircrafts outside of the parameters of which the law restricts us. We will only use these mechanisms to capture video and footage at or around the Orlando Citrus Bowl Stadium for the promotion of events and football ga mes that happen within.
Thanks for your time , Reginald Parks, Marketing Manager Florida Citrus Sports FCSports.com
### D ISTRICT 

### C OURT 

### O F 

### A PPEAL 

### O F 

### T HE 

### S TATE 

### O F 

### F LORIDA
F OURTH D ISTRICT

MICHAEL SWAYZE , Appellant,

v.

STATE OF FLORIDA , Appellee

.

No. 4D 18

- 1631

[August 23, 2018 ]

Appeal of order denying rule 3.850 motion from the Circuit Court for the Seventeenth Judicial Circuit, Broward County ; Andrew L. Siegel

, Judge; L.T. Case No. 16

- 11544CF10A

.
Michael Swayze, Perry, pro se.

No appearance required for appellee.

P ER C URIAM

.
Affirmed

.

G ROSS , M AY and K UNTZ , JJ., concur.

* * *

Not final until disposition of timely filed motion for rehearing.
```

[Federal Register Volume 74, Number 78 (Friday, April 24, 2009)]
[Notices]
[Page 18804]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-9379]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF THE TREASURY

Submission for OMB Review; Comment Request

April 20, 2009.
    The Department of the Treasury will submit the following public 
information collection requirement(s) to OMB for review and clearance 
under the Paperwork Reduction Act of 1995, Public Law 104-13 on or 
after the date of publication of this notice. Copies of the 
submission(s) may be obtained by calling the Treasury Bureau Clearance 
Officer listed. Comments regarding this information collection should 
be addressed to the OMB reviewer listed and to the Treasury Department 
Clearance Officer, Department of the Treasury, Room 11000, and 1750 
Pennsylvania Avenue, NW., Washington, DC 20220.

DATES: Written comments should be received on or before May 26, 2009 to 
be assured of consideration.

Internal Revenue Service (IRS)

    OMB Number: 1545-1961.
    Type of Review: Extension.
    Form: 1127.
    Title: Application for Extension of Time for Payment of Tax.
    Description: Form 1127 is used by taxpayers to request extension of 
time to pay taxes. The conditions under which extensions may be granted 
are stated under Section 6161 of the Internal Revenue Code.
    Respondents: Individuals or Households.
    Estimated Total Burden Hours: 833 hours.

    OMB Number: 1545-2121.
    Type of Review: Extension.
    Title: Announcement 2008-103, Exported Coal Refund.
    Description: This Announcement provides guidance to taxpayers 
regarding the filing of a claim for refund of the coal tax paid on 
exported coal. The guidance includes the form on which the claim is to 
be filed and the additional information needed to substantiate a claim.
    Respondents: Businesses or other for-profits.
    Estimated Total Burden Hours: 600 hours.
    Clearance Officer: R. Joseph Durbala, (202) 622-3634, Internal 
Revenue Service, Room 6516, 1111 Constitution Avenue, NW., Washington, 
DC 20224.
    OMB Reviewer: Shagufta Ahmed, (202) 395-7873, Office of Management 
and Budget, Room 10235, New Executive Office Building, Washington, DC 
20503.

Celina Elphage,
Treasury PRA Clearance Officer.
[FR Doc. E9-9379 Filed 4-23-09; 8:45 am]
BILLING CODE 4830-01-P
```
Exhibit
32.1





CERTIFICATION
PURSUANT TO


18
U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002





Pursuant
to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, the undersigned hereby certifies that, to his
knowledge, the annual report on Form 10-KSB (the “Report”) of Intermost
Corporation, a Wyoming corporation (the “Company”), for the period ended June
30, 2008:





1.           Fully
complies with the requirements of Section 13(a) or 15(d), as applicable, of the
Securities Exchange Act of 1934, as amended; and




2.           The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.





This certification is being provided
pursuant to 18 U.S.C. 1350 and is not to be deemed a part of this Report, nor is
it to be deemed to be “filed” for any purpose whatsoever.








Date:
November 6,
2008


By:       /s/ Rocky
Wulianghai


Rocky
Wulianghai, Chief Executive Officer





A
signed original of this written statement required by Section 906 of the
Sarbanes-Oxley Act of 2002 has been provided to the Company, and will be
retained by the Company, and furnished to the Securities and Exchange Commission
upon request.
II 

112TH CONGRESS 

2D SESSION S. 3102 

To suspend temporarily the duty on mixtures of 2,7-naphthalenedisulfonic 

acid, 4-amino-5-hydroxy-6-[2-[2- methoxy-5-[[2- (sulfooxy) ethyl] 

sulfonyl]phenyl]diazenyl]-3-[2-[4-[[2-(sulfooxy)ethyl] sulfonyl] 

phenyl]diazenyl]-, sodium salt (1:4) and 2,7-Naphthalenedisulfonic acid, 

4-amino-5-hydroxy-3,6-bis[2-[4-[[2-(sulfooxy)ethyl] 

sulfonyl]phenyl]diazenyl]-, sodium salt (1:4). 

IN THE SENATE OF THE UNITED STATES 

MAY 10, 2012 

Mrs. HAGAN introduced the following bill; which was read twice and referred 

to the Committee on Finance 

A BILL 

To suspend temporarily the duty on mixtures of 2,7- 

naphthalenedisulfonic acid, 4-amino-5-hydroxy-6-[2-[2- 

methoxy-5-[[2- (sulfooxy) ethyl] 

sulfonyl]phenyl]diazenyl]-3-[2-[4-[[2-(sulfooxy)ethyl] 

sulfonyl] phenyl]diazenyl]-, sodium salt (1:4) and 2,7- 

Naphthalenedisulfonic acid, 4-amino-5-hydroxy-3,6-bis[2- 

[4-[[2-(sulfooxy)ethyl] sulfonyl]phenyl]diazenyl]-, sodium 

salt (1:4). 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 


srobinson on DSK4SPTVN1PROD with BILLS
2 

•S 3102 IS

1 SECTION 1. MIXTURES OF 2,7-NAPHTHALENEDISULFONIC 

2 ACID, 4-AMINO-5-HYDROXY-6-[2-[2- METHOXY-5- 

3 [[2- (SULFOOXY) ETHYL] 

4 SULFONYL]PHENYL]DIAZENYL]-3-[2-[4-[[2- 

5 (SULFOOXY)ETHYL] SULFONYL] 

6 PHENYL]DIAZENYL]-, SODIUM SALT (1:4) AND 

7 2,7-NAPHTHALENEDISULFONIC ACID, 4- 

8 AMINO-5-HYDROXY-3,6-BIS[2-[4-[[2- 

9 (SULFOOXY)ETHYL] 

10 SULFONYL]PHENYL]DIAZENYL]-, SODIUM 

11 SALT (1:4). 

12 (a) IN GENERAL.—Subchapter II of chapter 99 of 

13 the Harmonized Tariff Schedule of the United States is 

14 amended by inserting in numerical sequence the following 

15 new heading: 

‘‘ 9902.01.00 Mixtures of 2,7- 

Naphthalenedisulfonic acid, 

4-amino-5-hydroxy-6-[2-[2- 

methoxy-5-[[2- (sulfooxy) 

ethyl] 

sulfonyl]phenyl]diazenyl]-3- 

[2-[4-[[2-(sulfooxy)ethyl] 

sulfonyl] phenyl]diazenyl]-, 

sodium salt (1:4) (CAS No. 

93951–21–4) and 2,7- 

Naphthalenedisulfonic acid, 

4-amino-5-hydroxy-3,6-bis[2- 

[4-[[2-(sulfooxy)ethyl] 

sulfonyl]phenyl]diazenyl]-, sodium salt (1:4) (CAS No. 

17095–24–8) (provided for in 

subheading 3204.16.30) ........ Free No change No change On or before 

12/31/2015 ’’. 

16 (b) EFFECTIVE DATE.—The amendment made by 

17 subsection (a) applies with respect to goods entered, or 


srobinson on DSK4SPTVN1PROD with BILLS
3 

•S 3102 IS

1 withdrawn from warehouse for consumption, on or after 

2 the 15th day after the date of the enactment of this Act. 

Æ 


srobinson on DSK4SPTVN1PROD with BILLS